◎Sandra E. Peterson氏が12月にジョンソン・エンド・ジョンソンに入社

AsiaNet 50648

共同JBN 1179（2012.9.14）

◎Sandra E. Peterson氏が12月にジョンソン・エンド・ジョンソンに入社

【ニューブランズウィック（米ニュージャージー州）2012年9月13日PRN＝共同JBN】サンドラ・E・ピータースン（Sandra E. Peterson）氏が今年12月1日付けで、ジョンソン・エンド・ジョンソン（Johnson & Johnson、NYSE：JNJ）にGroup Worldwide Chairmanおよび同社Executive Committeeメンバーとして就任する。同氏は企業、情報技術、グローバル・サプライチェーン向けの消費者グループを担当する。

ピータースン氏は現在、欧州を本拠とするバイエル・クロップサイエンス（Bayer CropScience AG）の会長および最高経営責任者（CEO）を務めている。同氏は製薬、医療機器、消費財、ヘルスケア代理店、戦略的開発において、ざまざまな関連性のある世界的な経験を積んできた。

アレックス・ゴルスキー最高経営責任者（CEO）は「ピータースン氏は経験豊富な世界的なリーダーであり、成長ビジネスにおいて戦略的な思考と実績を挙げたことで有名である。同氏は就任する新しい職務に25年間の経験をもたらし、完全一体化した世界事業を構築し成長に専念するうえで同氏の専門的知識を生かすことになる」と述べた。

ピータースン氏は2010年から、バイエルでの現職を務めてきた。それ以前には、Bayer Medical Careのプレジデント兼CEO、Bayer Medical Careの糖尿病ケア部門のプレジデントを歴任した。

ピータースン氏は2005年Bayerに入社したが。それ以前にはMedco Health Solutionsで指導的な地位を5年間務めた。同氏はナビスコ（Nabisco, Inc.）で世界的な研究開発、調達、規制関連業務、Whirlpool Corporationで戦略、財務、製品開発を指揮した。同氏はマッキンゼー・アンド・カンパニー（McKinsey & Company, Inc.）でのコンサルタント業務がキャリアの最初だった。

ピータースン氏はコーネル大学行政学位を取得、さらにプリンストン大学で応用経済学行政修士号を取得した。同氏はDun & Bradstreet Corporationの取締会役員である。

ピータースン氏は現在ドイツに在住し、今後は米ニュージャージー州ニューブランズウィックにあるジョンソン・エンド・ジョンソン本社を拠点とする。

▽ジョンソン・エンド・ジョンソン（Johnson & Johnson）について

世界と同時に個人のケアリングは、ジョンソン・エンド・ジョンソン社員を鼓舞し、団結させる。われわれは研究と科学を受け入れ、人々の健康と福祉を増進する革新的アイディアと製品、サービスをもたらす。250社余りのジョンソン・エンド・ジョンソン傘下企業で働く12万8000人の社員は、ヘルスケア分野のパートナーと協力して、世界で毎日10億以上の人々の生命に触れる。

ソース：Johnson & Johnson

▽問い合わせ先

Media:

Carol Goodrich,

+1-732-524-6678, or +1-973-615-4057 (Mobile),

Or

Investors:

Louise Mehrotra,

+1-732-524-6491

Sandra E. Peterson to Join Johnson & Johnson as Group Worldwide Chairman and Member of the Executive Committee

PR50648

NEW BRUNSWICK, N.J., Sept. 13, 2012 /PRN=KYODO JBN/ --

Sandra E. Peterson will join Johnson & Johnson (NYSE: JNJ) on December 1, 2012,

as Group Worldwide Chairman and member of the Company's Executive Committee.

She will have responsibility for the Consumer Group of Companies, Information

Technology, and Global Supply Chain.

Currently the Chairman and Chief Executive Officer of Bayer CropScience AG,

based in Europe, Peterson has diverse and relevant global experience in

pharmaceuticals, medical devices, consumer goods, healthcare intermediaries and

strategy development.

"Sandi Peterson is an experienced global leader known for her strategic

thinking and proven track record in growing businesses," said Alex Gorsky,

Chief Executive Officer. "She brings 25 years of experience to her new role,

which will draw on her expertise in building fully integrated global

businesses, and focusing on growth."

Peterson has held her current role at Bayer since 2010. Previously, she was

president and chief executive officer of Bayer Medical Care and president of

Bayer HealthCare AG's Diabetes Care Division.

Prior to joining Bayer in 2005, Peterson spent five years in leadership roles

at Medco Health Solutions. She previously led global research and development,

procurement and regulatory affairs at Nabisco, Inc., and in strategy, finance

and product development at Whirlpool Corporation. She began her career in

consulting, with McKinsey & Company, Inc.

A graduate of Cornell University with a B.A. in Government, Peterson also holds

an M.P.A. in Applied Economics from Princeton University. She is a member of

the board of directors of The Dun & Bradstreet Corporation.

Currently residing in Germany, Peterson will be based at Johnson & Johnson

headquarters in New Brunswick, New Jersey.

About Johnson & Johnson

Caring for the world, one person at a time... inspires and unites the people of

Johnson & Johnson. We embrace research and science - bringing innovative ideas,

products and services to advance the health and well-being of people. Our

approximately 128,000 employees at more than 250 Johnson & Johnson operating

companies work with partners in health care to touch the lives of over a

billion people every day, throughout the world.

(This press release contains "forward-looking statements" as defined in the

Private Securities Litigation Reform Act of 1995.  The reader is cautioned not

to rely on these forward-looking statements. These statements are based on

current expectations of future events.  If underlying assumptions prove

inaccurate or unknown risks or uncertainties materialize, actual results could

vary materially from the expectations and projections of Johnson & Johnson.  

Risks and uncertainties include, but are not limited to, general industry

conditions and competition; economic factors, such as interest rate and

currency exchange rate fluctuations; technological advances, new products and

patents attained by competitors; challenges inherent in new product

development, including obtaining regulatory approvals; challenges to patents;

significant adverse litigation or government action; impact of business

combinations; financial distress and bankruptcies experienced by significant

customers and suppliers; changes to governmental laws and regulations and

domestic and foreign health care reforms; trends toward health care cost

containment; increased scrutiny of the health care industry by government

agencies; changes in behavior and spending patterns of purchasers of health

care products and services; financial instability of international economies

and sovereign risk; disruptions due to natural disasters; manufacturing

difficulties or delays; and product efficacy or safety concerns resulting in

product recalls or regulatory action. A further list and description of these

risks, uncertainties and other factors can be found in Exhibit 99 of Johnson &

Johnson's Annual Report on Form 10-K for the fiscal year ended January 1,

2012.  Copies of this Form 10-K, as well as subsequent filings, are available

online at http://www.sec.gov, http://www.jnj.com or on request from Johnson &

Johnson. Johnson & Johnson does not undertake to update any forward-looking

statements as a result of new information or future events or developments.)

SOURCE  Johnson & Johnson

CONTACT:  Media: Carol Goodrich, +1-732-524-6678, or +1-973-615-4057 (Mobile),

or Investors: Louise Mehrotra, +1-732-524-6491